These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11444411)

  • 61. Acute irreversible oxalate nephropathy in a lung transplant recipient treated successfully with a renal transplant.
    Dheda S; Swaminathan R; Musk M; Sinniah R; Lawrence S; Irish A
    Nephrology (Carlton); 2012 Apr; 17 Suppl 1():12-5. PubMed ID: 22497648
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enteric hyperoxaluria and renal failure associated with lymphangiectasia.
    Allen A; Clutterbuck E; Maidment G; Thompson E; Watts R; Pusey C
    Nephrol Dial Transplant; 1997 Apr; 12(4):802-6. PubMed ID: 9141019
    [No Abstract]   [Full Text] [Related]  

  • 63. Surgical management of the failed jejunoileal bypass.
    Pessa M; Robertson J; Woodward ER
    Am J Surg; 1986 Mar; 151(3):364-7. PubMed ID: 3953955
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Urinary calculi and jejunoileal bypass operation. A long-term follow-up.
    Annuk M; Backman U; Holmgren K; Vessby B
    Scand J Urol Nephrol; 1998 May; 32(3):177-80. PubMed ID: 9689695
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Medical Management of Advanced Oxalate Nephropathy Secondary to Gastric Bypass Surgery.
    Kamel TH; Maroz N
    Am J Med Sci; 2021 Apr; 361(4):517-521. PubMed ID: 33187632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Renal tubular acidosis secondary to jejunoileal bypass for morbid obesity.
    Schaffalitzky de Muckadell OB; Ladefoged J; Thorup J
    Scand J Gastroenterol; 1985 Sep; 20(7):823-8. PubMed ID: 4048834
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.
    Glew RH; Sun Y; Horowitz BL; Konstantinov KN; Barry M; Fair JR; Massie L; Tzamaloukas AH
    World J Nephrol; 2014 Nov; 3(4):122-42. PubMed ID: 25374807
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Liver transplantation after jejunoileal bypass for morbid obesity.
    Lowell JA; Shenoy S; Ghalib R; Caldwell C; White FV; Peters M; Howard TK
    J Am Coll Surg; 1997 Aug; 185(2):123-7. PubMed ID: 9249079
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oxalate degradation by gastrointestinal bacteria from humans.
    Allison MJ; Cook HM; Milne DB; Gallagher S; Clayman RV
    J Nutr; 1986 Mar; 116(3):455-60. PubMed ID: 3950772
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renal AA amyloidosis--a long-term sequela of jejuno-ileal bypass.
    Korzets Z; Smorjik Y; Zahavi T; Bernheim J; Bernheim J
    Nephrol Dial Transplant; 1998 Jul; 13(7):1843-5. PubMed ID: 9681744
    [No Abstract]   [Full Text] [Related]  

  • 71. Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.
    Ligon CB; Hummers LK; McMahan ZH
    Semin Arthritis Rheum; 2015 Dec; 45(3):315-20. PubMed ID: 26239907
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass.
    Agrawal V; Wilfong JB; Rich CE; Gibson PC
    Case Rep Nephrol Dial; 2016; 6(3):114-119. PubMed ID: 27781207
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gastric partition after reversal of jejunoileal bypass for morbid obesity: three-year follow-up.
    Robertson JW; Woodward ER
    South Med J; 1985 Nov; 78(11):1314-6. PubMed ID: 4071137
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical Outcomes and Histological Patterns in Oxalate Nephropathy due to Enteric and Nonenteric Risk Factors.
    Reddy S; Bolen E; Abdelmalek M; Lieske JC; Ryan M; Keddis MT
    Am J Nephrol; 2021; 52(12):961-968. PubMed ID: 34844241
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reversal of Roux-en-Y Gastric Bypass for Successful Salvage of Renal Allograft.
    Hrebinko K; Moroni E; Ganoza A; Puttarajappa CM; Molinari M; Sood P; El Hag M; Wijkstrom M; Tevar AD
    Am Surg; 2023 Apr; 89(4):1286-1289. PubMed ID: 33631945
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enteric hyperoxaluria: an important cause of end-stage kidney disease.
    Nazzal L; Puri S; Goldfarb DS
    Nephrol Dial Transplant; 2016 Mar; 31(3):375-82. PubMed ID: 25701816
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oral manifestations of oxalosis secondary to ileojejunal intestinal bypass.
    Lapointe HJ; Listrom R
    Oral Surg Oral Med Oral Pathol; 1988 Jan; 65(1):76-80. PubMed ID: 3422399
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hyperoxaluria: an underestimated cause of rapidly progressive renal failure.
    Tintillier M; Pochet JM; Blackburn D; Delgrange E; Donckier JE
    Acta Clin Belg; 2001; 56(6):360-3. PubMed ID: 11881321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Jejunoileal bypass: a surgery of the past and a review of its complications.
    Singh D; Laya AS; Clarkston WK; Allen MJ
    World J Gastroenterol; 2009 May; 15(18):2277-9. PubMed ID: 19437570
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oxalic acid excretion after intravenous ascorbic acid administration.
    Robitaille L; Mamer OA; Miller WH; Levine M; Assouline S; Melnychuk D; Rousseau C; Hoffer LJ
    Metabolism; 2009 Feb; 58(2):263-9. PubMed ID: 19154961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.